Recombinant Human SUMO2 Protein，His

SUMO2 (Small Ubiquitin-like Modifier 2) is a member of the SUMO (Small Ubiquitin-like Modifier) protein family, which plays a critical role in various cellular processes through a post-translational modification known as SUMOylation. This modification regulates protein stability, localization, and interactions, thereby influencing numerous cellular pathways, including DNA repair, cell proliferation, and stress responses. SUMO2, in particular, has garnered attention due to its unique functional properties and involvement in the regulation of numerous target proteins under physiological and pathological conditions. Its dysregulation has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. The study of SUMO2 recombinant proteins has emerged as a promising avenue for understanding the mechanisms of SUMOylation and its impact on cellular functions. By producing SUMO2 in a recombinant system, researchers can investigate its biochemical properties, interactions with specific substrates, and the effects of SUMOylation on these proteins. Furthermore, the development of SUMO2-based therapeutics is an exciting prospect, as it may enable the modulation of SUMOylation pathways to restore cellular balance in disease contexts. Overall, the research on SUMO2 recombinant proteins provides valuable insights into the fundamental biology of SUMOylation and its potential applications in disease treatment and prevention.